Soluble ST2
2 papers1 finding
- Human trial1
Interventions
1Canagliflozin
no changein humans1
1 study
Canagliflozin
no changein humans1
Canagliflozin has no effect on soluble ST2 in humans.
“Serum sST2 was unchanged with canagliflozin and placebo over 104 weeks.”
Human trialin older patients with T2DM104 weeks
Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
Journal of the American College of Cardiology12 Jun 2017
Latest
1 in 12 monthsBiochemical and Biophysical Research Communications
Mechanism-based biomarkers for early detection and plaque vulnerability assessment in atherosclerosis
ReviewAtherosclerosis
Journal of the American College of Cardiology
Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
Randomised trial in 666 peopleCanagliflozin